Shandong Pharmaceutical Glass Co.Ltd (SHA: 600529)

Shandong Pharmaceutical Glass Co.Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,088	1,466	1,352	885.04	1,132	1,060
Trading Asset Securities	1,706	1,218	1,101	307.13	230.5	461.84
Cash & Short-Term Investments	2,794	2,684	2,453	1,192	1,362	1,522
Cash Growth	15.32%	9.40%	105.80%	-12.49%	-10.48%	-6.20%
Accounts Receivable	1,836	1,701	1,551	1,200	943.19	696.23
Other Receivables	1.78	1.78	2.24	3.38	5.39	17.59
Receivables	1,838	1,703	1,553	1,203	948.58	713.83
Inventory	1,206	1,055	1,210	877.74	749.2	679.36
Prepaid Expenses	-	-	-	-	1.48	-
Other Current Assets	106.89	103.8	104.63	61.99	82.5	88.31
Total Current Assets	5,945	5,546	5,321	3,335	3,144	3,003
Property, Plant & Equipment	3,718	3,465	2,821	2,557	2,113	1,931
Long-Term Investments	0.05	0.05	0.05	0.05	0.05	0.05
Other Intangible Assets	248.93	253.67	260.37	198.37	203.25	171.81
Long-Term Deferred Tax Assets	38.58	37.8	32.01	32.42	29.63	25.19
Other Long-Term Assets	28.35	16.79	349.91	287.01	131.71	39.24
Total Assets	9,979	9,319	8,784	6,410	5,621	5,170
Accounts Payable	1,472	1,394	1,418	1,436	995.78	996.17
Accrued Expenses	119.67	149.8	130.47	126.18	153.21	80.73
Short-Term Debt	-	1.83	5.2	-	-	-
Current Income Taxes Payable	-	16.65	14.87	15.25	43.53	21.3
Current Unearned Revenue	58.95	61.79	51.04	74.61	64.68	-
Other Current Liabilities	429.75	102.83	144.13	27.74	48.33	154.59
Total Current Liabilities	2,081	1,727	1,764	1,679	1,306	1,253
Long-Term Unearned Revenue	110.7	57.62	58.95	59.97	60	49.71
Total Liabilities	2,191	1,784	1,823	1,739	1,366	1,302
Common Stock	663.61	663.61	663.61	594.97	594.97	594.97
Additional Paid-In Capital	2,687	2,687	2,687	913.45	913.45	913.45
Retained Earnings	4,368	4,112	3,535	3,096	2,683	2,297
Comprehensive Income & Other	68.78	71.59	75.48	66.22	64.4	62.24
Total Common Equity	7,788	7,535	6,962	4,670	4,256	3,868
Shareholders' Equity	7,788	7,535	6,962	4,670	4,256	3,868
Total Liabilities & Equity	9,979	9,319	8,784	6,410	5,621	5,170
Total Debt	-	1.83	5.2	-	-	-
Net Cash (Debt)	2,794	2,682	2,448	1,192	1,362	1,522
Net Cash Growth	15.57%	9.56%	105.36%	-12.49%	-10.48%	-6.20%
Net Cash Per Share	4.21	4.05	4.08	2.00	2.29	2.55
Filing Date Shares Outstanding	663.61	663.61	663.61	594.97	594.97	594.97
Total Common Shares Outstanding	663.61	663.61	663.61	594.97	594.97	594.97
Working Capital	3,864	3,819	3,557	1,656	1,839	1,750
Book Value Per Share	11.74	11.35	10.49	7.85	7.15	6.50
Tangible Book Value	7,539	7,281	6,701	4,472	4,053	3,696
Tangible Book Value Per Share	11.36	10.97	10.10	7.52	6.81	6.21
Buildings	-	1,911	1,507	1,402	1,184	1,154
Machinery	-	1,086	983.08	2,004	1,673	1,591
Construction In Progress	-	470.14	475.18	342.58	314.88	167.85

Source: S&P Capital IQ. Standard template. Financial Sources.